A closer look at the role of deubiquitinating enzymes in the Hypoxia Inducible Factor pathway
Biochemical Society Transactions · 19.12.2024 · 52 (6) · 2253-2265
DOI: 10.1042/bst20230861 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, online erschienen am 25.11.2024. Verfasst von Tekle Pauzaite und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah, Biomedical Centre, Department of Medicine, University of …. Hauptthemen laut MEDLINE: Signal Transduction, Ubiquitination, Von Hippel-Lindau Tumor Suppressor Protein. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
Hypoxia Inducible transcription Factors (HIFs) are central to the metazoan oxygen-sensing response. Under low oxygen conditions (hypoxia), HIFs are stabilised and govern an adaptive transcriptional programme to cope with prolonged oxygen starvation. However, when oxygen is present, HIFs are continuously degraded by the proteasome in a process involving prolyl hydroxylation and subsequent ubiquitination by the Von Hippel Lindau (VHL) E3 ligase. The essential nature of VHL in the HIF response is well established but the role of other enzymes involved in ubiquitination is less clear. Deubiquitinating enzymes (DUBs) counteract ubiquitination and provide an important regulatory aspect to many signalling pathways involving ubiquitination. In this review, we look at the complex network of ubiquitination and deubiquitination in controlling HIF signalling in normal and low oxygen tensions. We discuss the relative importance of DUBs in opposing VHL, and explore roles of DUBs more broadly in hypoxia, in both VHL and HIF independent contexts. We also consider the catalytic and non-catalytic roles of DUBs, and elaborate on the potential benefits and challenges of inhibiting these enzymes for therapeutic use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah, Biomedical Centre, Department of Medicine, University of Cambridge, Cambridge CB2 0AW, U.K.
ORCID-Profile: James A Nathan
Förderung
- Wellcome Trust
Zitieren
APA
Pauzaite, T., & Nathan, J. A. (2024). A closer look at the role of deubiquitinating enzymes in the Hypoxia Inducible Factor pathway. Biochemical Society Transactions, 52(6), 2253-2265. https://doi.org/10.1042/bst20230861
Vancouver
Pauzaite T, Nathan JA. A closer look at the role of deubiquitinating enzymes in the Hypoxia Inducible Factor pathway. Biochemical Society Transactions. 2024;52(6):2253-2265. doi:10.1042/bst20230861
BibTeX
@article{Pauzaite2024,
author = {Pauzaite, Tekle and Nathan, James A},
title = {A closer look at the role of deubiquitinating enzymes in the Hypoxia Inducible Factor pathway},
journal = {Biochemical Society Transactions},
year = {2024},
volume = {52},
number = {6},
pages = {2253--2265},
doi = {10.1042/bst20230861}
}
EUVIMED